-
Loading metrics
Divergent role of Mitochondrial Amidoxime Reducing Component 1 (MARC1) in human and mouse
-
Eriks Smagris,
Roles Data curation, Formal analysis, Investigation, Methodology, Project administration, Validation, Writing – original draft, Writing – review & editing
Affiliation Regeneron Pharmaceuticals, Tarrytown, New York, Unites States of America
⨯ - Lisa M. Shihanian,
- Ivory J. Mintah,
- Parnian Bigdelou,
- Yuliya Livson,
- Heather Brown,
- Niek Verweij,
-
Charleen Hunt,
Roles Supervision, Writing – review & editing
Affiliation Regeneron Pharmaceuticals, Tarrytown, New York, Unites States of America
⨯ - Reid O’Brien Johnson,
-
Tyler J. Greer,
Roles Writing – review & editing
Affiliation Regeneron Pharmaceuticals, Tarrytown, New York, Unites States of America
⨯ -
Suzanne A. Hartford,
Roles Supervision, Writing – review & editing
Affiliation Regeneron Pharmaceuticals, Tarrytown, New York, Unites States of America
⨯ - George Hindy,
- Luanluan Sun,
-
Jonas B. Nielsen,
Roles Writing – review & editing
Affiliation Regeneron Pharmaceuticals, Tarrytown, New York, Unites States of America
⨯ - Gabor Halasz,
- Luca A. Lotta,
- Andrew J. Murphy,
- Mark W. Sleeman,
- [ ... ],
- Viktoria Gusarova
- [ view all ]
- [ view less ]
https://orcid.org/0000-0002-5311-2685
Divergent role of Mitochondrial Amidoxime Reducing Component 1 (MARC1) in human and mouse
- Eriks Smagris,
- Lisa M. Shihanian,
- Ivory J. Mintah,
- Parnian Bigdelou,
- Yuliya Livson,
- Heather Brown,
- Niek Verweij,
- Charleen Hunt,
- Reid O’Brien Johnson,
- Tyler J. Greer
-
- Published: March 4, 2024
- https://doi.org/10.1371/journal.pgen.1011179